Rainier Therapeutics

About:

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

Website: https://www.rainierrx.com/

Top Investors: Novo Holdings, EQT Life Sciences, Sofinnova Investments, Inkef, Sectoral Asset Management

Description:

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.The company's technology uses Vofatamab, a human monoclonal antibody that targets and specifically blocks the activity of FGFR3 (fibroblast growth factor receptor 3), enabling medical practitioners to treat patients with early stage and metastatic bladder cancer effectively.